TIL · XBRL financial data
Instil Bio financial statements, every quarter
The same tables from 13 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (TIL's year ends in late December)
- ‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (December 2023); filings made before it reported them unadjusted.
Balance sheet
CSVFiscal quarters (TIL's year ends in late December)
- ‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (December 2023); filings made before it reported them unadjusted.
Cash flows
CSVFiscal quarters (TIL's year ends in late December)
| In thousands of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | (67,432) | (12,925)* | (24,302) | (14,917) | (23,021) | (11,895)* | (28,200) | (21,394) | (13,587) | (8,191)* | (4,204) | (4,299) |
| Stock-based compensation | 4,670* | 4,553* | 4,515 | 4,173* | 4,068* | 4,501* | 3,495 | 1,824* | 1,768* | 1,606* | 985 | 1,036* |
| Depreciation and amortization | 953* | 1,036* | 993 | 975* | 901* | 741* | 498 | 12* | 12* | 12* | 12 | 248* |
| Net cash from operating activities | (14,426)* | (13,381)* | (14,392) | (10,612)* | (20,133)* | (10,559)* | (4,195) | (14,791)* | (10,557)* | (7,076)* | (1,337) | (4,642)* |
| Purchases of property and equipment | 5,158* | 58* | 0 | 0* | 0* | 0* | — | — | — | — | — | — |
| Net cash from investing activities | 2,319* | 13,950* | 9,243 | 11,917* | 19,814* | 13,000* | 9,611 | (400)* | 8,447* | 7,818* | (317) | 5,291* |
| Proceeds from issuing common stock | — | — | — | — | 0* | 0* | — | — | 0* | 0* | — | — |
| Net cash from financing activities | (587)* | 0* | 0 | 0* | 159* | 1,596* | 232 | 6,682* | 378* | 0* | 0 | 0* |
Compare with peers
The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.
Not investment advice. Not affiliated with the U.S. SEC.